Maternal vaccination: a review of current evidence and recommendations

M Etti, A Calvert, E Galiza, S Lim, A Khalil… - American Journal of …, 2022 - Elsevier
Maternal vaccination is an effective means of protecting pregnant women, their fetuses, and
infants from vaccine-preventable infections. Despite the availability of sufficient safety data to …

Pertussis: microbiology, disease, treatment, and prevention

PE Kilgore, AM Salim, MJ Zervos… - Clinical microbiology …, 2016 - Am Soc Microbiol
Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …

JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

FM Munoz, NH Bond, M Maccato, P Pinell, HA Hammill… - Jama, 2014 - jamanetwork.com
Importance Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and
acellular pertussis (Tdap) vaccine could prevent infant pertussis. Objective To evaluate the …

Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis

CS Eberhardt, G Blanchard-Rohner… - Clinical Infectious …, 2016 - academic.oup.com
Background. Maternal immunization against pertussis is currently recommended after the
26th gestational week (GW). Data on the optimal timing of maternal immunization are …

Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review

S Vygen-Bonnet, W Hellenbrand, E Garbe… - BMC infectious …, 2020 - Springer
Background Infants< 3 months of age are at highest risk for developing severe complications
after pertussis. The majority of pregnant women has low concentrations of pertussis-specific …

Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants< 2 months of age: a case-control …

TH Skoff, AE Blain, J Watt, K Scherzinger… - Clinical Infectious …, 2017 - academic.oup.com
Background Infants aged< 1 year are at highest risk for pertussis-related morbidity and
mortality. In 2012, Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) …

Strategies to decrease pertussis transmission to infants

K Forsyth, S Plotkin, T Tan, CH Wirsing von König - Pediatrics, 2015 - publications.aap.org
The Global Pertussis Initiative (GPI) is an expert scientific forum addressing the worldwide
burden of pertussis, which remains a serious health issue, especially in infants. This age …

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study …

SN Ladhani, NJ Andrews, J Southern… - Clinical infectious …, 2015 - academic.oup.com
Abstract Introduction. In England, antenatal pertussis immunization using a tetanus/low-dose
diphtheria/5-component acellular-pertussis/inactivated-polio (TdaP5/IPV) vaccine was …

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels–a prospective …

BA Raya, I Srugo, A Kessel, M Peterman, D Bader… - Vaccine, 2014 - Elsevier
Abstract Background The Centers for Disease Control and Prevention recommend Tdap
immunization during pregnancy, preferably at 27–36 weeks. Aim To ascertain whether there …